{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:45Z","timestamp":1740165885232,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the reports on glomerulonephritis associated with COVID-19 mRNA vaccines, no study has reported about the dense deposit disease (DDD). Here, we present a case of hilar lymphadenopathy after the COVID-19 mRNA vaccination, following which the patient developed tubulointerstitial nephritis (TIN) and DDD. A 74-year-old man received his second dose of mRNA vaccine, and on the next day, he developed fever, urticaria, and dyspnea. On further examination, he had pleural effusion and right hilar lymphadenopathies, which were improved with conservative therapy. After 48\u00a0days of the second vaccination, he developed renal dysfunction and new-onset hematuria. Light microscopy findings by renal biopsy revealed apparent mesangial cell proliferation, increased mesangial matrix in the glomeruli, and diffuse inflammatory cell infiltration in the interstitium. Immunofluorescence analysis revealed 1\u2009+\u2009positive results for IgG and IgM, negative results for IgA, and 2\u2009+\u2009positive results for C3 with a garland pattern on the capillary walls. Electron microscopy revealed that severe cell proliferation in the capillary rumen, and continuous, thickened, and highly dark-stained spotty dense deposits in the glomerular basement membrane; and noncontinuous spotty dense deposits in the tubular basement membrane. Based on the decrease in C3 and pathological findings, TIN accompanied with DDD was diagnosed. The mRNA vaccine might have contributed to the development of lymphadenopathies, TIN, and DDD in this case. Moreover, TIN and DDD might be associated with the activated alternative pathway induced by the mRNA vaccine.<\/jats:p>","DOI":"10.1007\/s13730-022-00762-7","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T17:03:29Z","timestamp":1670951009000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0066-8070","authenticated-orcid":false,"given":"Hironori","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Anayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","volume":"78","author":"MT Shakoor","year":"2021","unstructured":"Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78:611\u20133.","journal-title":"Am J Kidney Dis"},{"key":"762_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.kint.2021.06.006","volume":"100","author":"A Sacker","year":"2021","unstructured":"Sacker A, Kung V, Andeen N. Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination. Kidney Int. 2021;100:471\u20132.","journal-title":"Kidney Int"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.kint.2021.05.009","volume":"100","author":"HZ Tan","year":"2021","unstructured":"Tan HZ, Tan RY, Choo JCJ, et al. Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int. 2021;100:469\u201371.","journal-title":"Kidney Int"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.ajkd.2021.06.004","volume":"78","author":"AS Bomback","year":"2021","unstructured":"Bomback AS, Kudose S, D\u2019Agati VD. De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far? Am J Kidney Dis. 2021;78:477\u201380.","journal-title":"Am J Kidney Dis"},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/IJNRD.S345898","volume":"14","author":"FS Mira","year":"2021","unstructured":"Mira FS, Costa Carvalho J, de Almeida PA, et al. A case of acute interstitial nephritis after two doses of the BNT162b2 SARS-CoV-2 vaccine. Int J Nephrol Renovasc Dis. 2021;14:421\u20136.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000451069","volume":"45","author":"IC Macdougall","year":"2017","unstructured":"Macdougall IC, Vernon K. Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron. Am J Nephrol. 2017;45:60\u20132.","journal-title":"Am J Nephrol"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"W27","DOI":"10.2214\/AJR.21.25683","volume":"216","author":"M Cellina","year":"2021","unstructured":"Cellina M, Irmici G, Carrafiello G. Unilateral axillary lymphadenopathy after coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. 2021;216:W27.","journal-title":"AJR Am J Roentgenol"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","volume":"48","author":"RJ Smith","year":"2011","unstructured":"Smith RJ, Harris CL, Pickering MC. Dense deposit disease. Mol Immunol. 2011;48:1604\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2011.04.005.","journal-title":"Mol Immunol"},{"key":"762_CR9","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","volume":"177","author":"D Turnberg","year":"2006","unstructured":"Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol. 2006;177:4094\u2013102. https:\/\/doi.org\/10.4049\/jimmunol.177.6.4094.","journal-title":"J Immunol"},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cmi.2017.151","volume":"15","author":"Y Segal","year":"2018","unstructured":"Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15:586\u201394.","journal-title":"Cell Mol Immunol"},{"key":"762_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, et al. Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020;19: 102524.","journal-title":"Autoimmun Rev"},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1182\/blood.2020008248","volume":"136","author":"J Yu","year":"2020","unstructured":"Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020;136:2080\u20139.","journal-title":"Blood"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jconrel.2013.05.025","volume":"172","author":"MA Dobrovolskaia","year":"2013","unstructured":"Dobrovolskaia MA, McNeil SE. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release. 2013;172:456\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.025.","journal-title":"J Control Release"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00762-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00762-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00762-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T07:41:01Z","timestamp":1690875661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00762-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00762-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no relevant financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for the publication of the details of his medical case, performing genetic analysis and any accompanying images. Ethical approval was not required for this case report in accordance with the ethics review board of Shinonoi General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}